posted on 2020-09-10, 17:41authored byAda AdminAda Admin, Francesco Tecilazich, Toan A. Phan, Fabio Simeoni, Giulia Maria Scotti, Zeina Dagher, Mara Lorenzi
In diabetes there is a long latency between onset of
hyperglycemia and appearance of structural microangiopathy. Because Ly6C<sup>low</sup>
patrolling monocytes (PMo) behave as housekeepers of the vasculature, we tested
whether PMo protect microvessels against diabetes.
<p>We found that, in wild-type mice,<b> </b>diabetes
reduced PMo in the general circulation but increased by 4-fold the absolute
number of PMo adherent to retinal vessels (leukostasis). Conversely, in
diabetic NR4A1<sup>-/-</sup> mice ─ a
model of absence of PMo ─ there was no increase in leukostasis at all;
and at 6 months of diabetes the number
of retinal acellular capillaries almost doubled when compared to diabetic
wild-type mice. Circulating PMo showed gene expression changes indicative
of enhanced migratory, vasculo-protective, and housekeeping activities; as well
as profound suppression of genes related to inflammation and apoptosis.
Pro-migratory CXCR4 was no longer upregulated at longer duration, when retinal
acellular capillaries begin to increase.</p>
<p>Thus, after short diabetes duration, PMo are the cells
preferentially recruited to the retinal vessels and protect vessels from
diabetic damage. These observations support the need for reinterpretation
of the functional meaning of leukostasis in diabetes, and document within the
natural history of diabetic retinopathy processes of protection-repair that can
provide novel paradigms for prevention. </p>
Funding
This work was supported by the NIH (R21 EY024108 to M. Lorenzi); the Global Ophthalmology Award Program from Bayer to M. Lorenzi; the European Foundation for the Study of Diabetes (EFSD)/Boehringer Ingelheim European Research Programme in Microvascular Complications of Diabetes to F. Tecilazich and G. Zerbini; the Marie Skłodowska-Curie Actions 795877 to F. Tecilazich; the NIH National Eye Institute Core Grant P30EY003790; and the Italian Ministry of Health (5 x 1000).